🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 17 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/08/1995 | 34,62 | 35,09 | 33,69 | 34,62 | +0,00% | 4,05% | 181.727 |
| 08/08/1995 | 34,15 | 34,62 | 32,75 | 34,62 | +2,78% | 5,48% | 20.038 |
| 07/08/1995 | 34,15 | 34,15 | 32,75 | 33,69 | +0,00% | 4,11% | 5.450 |
| 04/08/1995 | 33,22 | 34,15 | 32,28 | 33,69 | +1,41% | 5,63% | 7.427 |
| 03/08/1995 | 34,15 | 34,15 | 32,75 | 33,22 | -4,05% | 4,11% | 17.045 |
| 02/08/1995 | 34,15 | 34,62 | 32,75 | 34,62 | +2,78% | 5,48% | 40.663 |
| 01/08/1995 | 33,92 | 34,15 | 32,75 | 33,69 | -1,37% | 4,14% | 20.572 |
| 31/07/1995 | 32,75 | 34,15 | 32,75 | 34,15 | +4,29% | 4,29% | 25.461 |
| 28/07/1995 | 33,69 | 34,62 | 32,75 | 32,75 | -5,41% | 5,56% | 44.964 |
| 27/07/1995 | 34,15 | 34,62 | 33,69 | 34,62 | +1,37% | 2,74% | 35.426 |
| 26/07/1995 | 34,15 | 34,15 | 32,75 | 34,15 | +1,39% | 4,11% | 70.318 |
| 25/07/1995 | 34,15 | 34,15 | 33,22 | 33,69 | +0,00% | 2,74% | 59.979 |
| 24/07/1995 | 32,75 | 34,15 | 32,28 | 33,69 | +2,86% | 5,71% | 94.577 |
| 21/07/1995 | 31,35 | 32,75 | 31,35 | 32,75 | +1,45% | 4,48% | 31.633 |
| 20/07/1995 | 30,41 | 32,75 | 30,41 | 32,28 | +1,47% | 7,69% | 23.618 |
| 19/07/1995 | 33,22 | 33,22 | 30,88 | 31,82 | -4,23% | 7,04% | 26.957 |
| 18/07/1995 | 33,69 | 33,69 | 31,82 | 33,22 | -1,39% | 5,56% | 18.381 |
| 17/07/1995 | 31,82 | 33,69 | 31,35 | 33,69 | +2,86% | 7,35% | 17.019 |
| 14/07/1995 | 31,82 | 33,22 | 31,35 | 32,75 | +1,45% | 5,88% | 7.668 |
| 13/07/1995 | 31,82 | 33,22 | 31,82 | 32,28 | -1,43% | 4,41% | 35.827 |
| 12/07/1995 | 33,22 | 33,22 | 31,82 | 32,75 | +2,94% | 4,23% | 40.930 |
| 11/07/1995 | 32,75 | 33,69 | 31,82 | 31,82 | +7,09% | 5,71% | 150.735 |
| 10/07/1995 | 29,94 | 30,88 | 29,01 | 29,71 | -3,79% | 6,25% | 26.797 |
| 07/07/1995 | 30,18 | 30,88 | 29,94 | 30,88 | +0,00% | 3,10% | 27.545 |
| 06/07/1995 | 31,35 | 31,82 | 29,94 | 30,88 | -2,94% | 5,97% | 9.618 |
| 05/07/1995 | 30,88 | 31,82 | 30,41 | 31,82 | +6,25% | 4,55% | 74.406 |
| 03/07/1995 | 31,35 | 31,35 | 29,94 | 29,94 | -3,03% | 4,48% | 16.244 |
| 30/06/1995 | 32,28 | 32,75 | 30,41 | 30,88 | +4,76% | 7,25% | 63.238 |
| 29/06/1995 | 30,88 | 30,88 | 29,48 | 29,48 | -1,56% | 4,55% | 16.297 |
| 28/06/1995 | 31,35 | 31,35 | 29,94 | 29,94 | -1,54% | 4,48% | 15.229 |